Developmental Language Difficulties: Behavioural and Electrophysiological Studies
NCT ID: NCT02872870
Last Updated: 2016-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
196 participants
OBSERVATIONAL
2012-03-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Understanding the Predictive Factors and the Neurocognitive Basis of Developmental Language Disorder
NCT04253600
Reading-FREE Markers for Early Detection of Developmental Dyslexia
NCT07072104
Language and Motricity in Preterm School Age Children
NCT02811029
Efficiency of Speech and Language Intervention on Achievement of Children With Developmental Language Disorder
NCT04926311
Developmental Dyslexia and Remediation Methods
NCT04028310
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control adults
lexical tests and electroencephalogram (EEG).
auditory lexical decision task
electroencephalogram
Dyslexic patients
lexical tests
auditory lexical decision task
electroencephalogram
Dysphasic patients
lexical tests
auditory lexical decision task
electroencephalogram
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
auditory lexical decision task
electroencephalogram
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Specific oral language disorders diagnosed by the multidisciplinary team (neurologist, psychologist, speech therapist): understanding language deficit, estimated by the test SCOTLAND (Lecocq, 1996) and / or vocabulary test (Dunn Thiébaud).
* Specific written language disorders (dyslexia) diagnosed by a multidisciplinary team according to a test that can objectify the late reading (Alouette) and locate deficits (EVALEC)
* Be affiliated to a social security regimen
* Have signed an informed consent or signed by the parents if the patient is minor
* Aged at least 8 years old
* Non-deficit (\>85) non-verbal Wechsler Scale (codes and matrices)
* No specific oral language disorders
* No specific written language disorders (dyslexia)
* Be affiliated to a social security regimen
* Have signed an informed consent or signed by the parents if the patient is minor
* Aged at least 8 years old
Exclusion Criteria
* Non-verbal reasoning abilities below 85 measured by the WISC 4 (for patients only) and Non-verbal capacities of reasoning lower than the normal measured by the non-verbal scale of Wechsler (for controls only)
* Presence of pervasive developmental disorders
* No affiliation to a social security regimen
* Absence of signature of the informed consent
* Subject of less than 8 years
8 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Lille 3
UNKNOWN
Université Catholique de Louvain
OTHER
Lille Catholic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Séverine Casalis
Role: STUDY_DIRECTOR
Université de Lille 3
Françoise Boidein, MD
Role: PRINCIPAL_INVESTIGATOR
Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Université catholique de Louvain (IPSY)
Louvain-la-Neuve, , Belgium
Hôpital Saint Vincent de Paul (GHICL)
Lille, , France
Université de Lille 3 Charles de Gaulle (URECA)
Villeneuve-d'Ascq, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC-P0020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.